title: Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers.
abstract: A series of unsymmetrically substituted 4-phenyl-1,4-dihydropyridine calcium entry blockers were investigated for their ability to relax potassium-contracted rabbit aortic smooth muscle and to competitively displace [3H]nitrendipine from its specific binding sites on guinea pig myocardial membranes in order to delineate the pharmacologically active conformer with respect to the position of the aromatic substituent (synperiplanar or antiperiplanar). The data show that the 1,4-dihydropyridine receptor distinguishes between 2',3'-disubstituted phenyldihydropyridines and 2',5'-disubstituted analogues as measured by changes of vasodilation and receptor affinity in vitro. The IC50 values for vasorelaxation by the analogues presented here correlate best with the Kd values for binding to the predominant receptor of two coexisting dihydropyridine binding sites in the guinea pig myocardium. We report the first observation of an antiperiplanar orientation of an o-phenyl substituent in the X-ray structure of 2-chlorophenyl analogue 3. Using nuclear Overhauser enhancement, we have developed a method that also demonstrates that an ortho (chloro or nitro) substituent on the phenyl ring does not preclude the presence of either synperiplanar or antiperiplanar phenyl rotamer in solution. These experimental findings contrast with the accepted belief that o-phenyl substituents essentially force these 1,4-dihydropyridines into the synperiplanar conformation exclusively.
authors.affiliation: Department of Chemistry/Cardiopulmonary, Squibb Institute for Medical Research, Princeton, New Jersey 08543-4000.
authors.forename: G
authors.initials: G
authors.lastname: Rovnyak
authors.forename: N
authors.initials: N
authors.lastname: Andersen
authors.forename: J
authors.initials: J
authors.lastname: Gougoutas
authors.forename: A
authors.initials: A
authors.lastname: Hedberg
authors.forename: S D
authors.initials: SD
authors.lastname: Kimball
authors.forename: M
authors.initials: M
authors.lastname: Malley
authors.forename: S
authors.initials: S
authors.lastname: Moreland
authors.forename: M
authors.initials: M
authors.lastname: Porubcan
authors.forename: A
authors.initials: A
authors.lastname: Pudzianowski
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D002121:Calcium Channel Blockers / Q000138:chemical synthesis / Q000378:metabolism; D015220:Calcium Channels; D004095:Dihydropyridines / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008958:Models, Molecular; D008968:Molecular Conformation; D009126:Muscle Relaxation / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D009543:Nifedipine / Q000378:metabolism; D011817:Rabbits; D011869:Radioligand Assay; D011978:Receptors, Nicotinic / Q000378:metabolism; D013329:Structure-Activity Relationship
chemical_list: D002121:Calcium Channel Blockers; D015220:Calcium Channels; D004095:Dihydropyridines; D011978:Receptors, Nicotinic; D009543:Nifedipine